Get started
bluebird bio, Inc.bluebird bio, Inc.bluebird bio, Inc.

bluebird bio, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

BLUE trade ideas

Blue Bird Harmonics: 1100% Gains in One to Two YearsFundamental Analysis: Blue Bird has suffered tremendous defeat in the stock market. Recently, a lawsuit was filed against Blue Bird, as backlash for failing to inform investors of changes with their expected timeline for completion of data release and FDA decisions. However, this coming March 27th Blue Bird is scheduled for a priority review of their joint PDUFA venture with Bristol-Myers Squibb Co. for their pivotal KarMMa study of Ide-cel in Relapsed and Refractory Multiple Myeloma. I would further venture to say that the lawsuit will fail. As you can see, from the harmonic here, the news should catapult them in a series of stock market wins. Technical Analysis: As blue Bird share price approaches the primary support which has held it up since it's inception, a double bottom reversal is expected. Normally, a double-bottom would fall within +/- 4% of this hugely critical support price. It's important to note that price may reverse within that double-bottom zone or exactly within the harmonic reversal zone. The share price of Blue bird should be picking up around March 29th, just as the short-lived market-wide correction begins to really take hold. The short-lived market-wide correction should last exclusively or inclusively, from - (These time ranges were found with two dynamic price-time analyses of the DAX and NASDAQ). Based upon the positive and negative linear slopes in the chart, we have two prices ranges. The price ranges correspond to the harmonic price ranges loosely. In this first chart, we have the overall move of a strong major monthly chart bearish cypher pattern, over several years. After this current C point turn, the cypher pattern is expected to complete from 1 - 2 years. The next pattern, posted below, shows a medium strength daily chart minor bullish butterfly, which usually forms at the bottom of a downtrend and indicates a prices reversal. A price reversal should occur at the D point of the butterfly pattern, over the next several days or couple weeks. Each chart shows the expected timeframe for a price reversal to occur within. It is time to buy or sell, whenever price meets the requirements of both harmonics. Good luck and best wishes!
NASDAQ:BLUELong
by Antikythera_Mechanism
9
BLUE has bottomedLove it or hate it, it's BLUE. Anecdotal, non-scientific evidence of a serious side effect prompted a halt of a trial of a product, and the company is investigating. No one knows anything else until the company reports. End. Of. Story. There is a strong bid today, and here you can see why. BLUE has clipped long-term support and bounced nicely off of it for it's largest intraday gain in (what seems like) a long time. My bet is that BLUE now remains in this ascending channel, which should entail some enjoyable rallies and frustrating pullbacks. You can sell $20/$25 put spreads and sleep at night, and the gamblers among you can buy calls in the upper half of the channel. Bon voyage, BLUE.
NASDAQ:BLUELong
by decaro
1
BLUE Technical Analysis 🧙Bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:BLUELong
by unfair_advantage
13
#Blue (Bluebird Bio) Gene therapeutics #BLUE is a candidate I've been watching for weeks. Bluebird bio is bio tech company that develops therapeutics for genetic diseases and cancer treatment. I posted this one originally on the 19th. My personal target will be 113.47 but we could ultimately see $137-163 beyond that in time. First target id expect to see is 72.37 if it ends up playing out. The bullish gartley is the same harmonic i used to call #AMC a couple weeks back when it was under $3.00. This formation is one of the most powerful reversal patterns in trading and can be signs of an incoming gamma squeeze. I do believe this is the case here. #BLUE reached $235 back in 2018, and id assume was shorted all the way down to 86, and initially as shorts exited, rose once again to 162 where (presumably) it was shorted into the ground once again. When these shorts are once again exited and this formation is complete, you will see the power behind bullish harmonics and a short squeeze YEARS in the making. Nothing is guaranteed in this market, and the S&P dropping won't help, but Im slowly adding to a position. This way if the price falls, I can average my way down until it reverses. This is generally my strategy with any asset. This is in no way advice, and I could be wrong (I know, it's hard to believe) but its one to keep an eye on, and one im taking a chance on personally.
NASDAQ:BLUELong
by TradingNomadic